Feb 24, 2022 / 05:40PM GMT
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research Analyst
Great. Thanks for joining us for our next session. My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team, and I also have the pleasure of covering animal health. And for our next fireside chat, we're pleased to be joined by Phibro Animal Health. With us, we have Damian Finio, CFO; and Daniel Bendheim, Executive VP. So Damian, Daniel, thanks for joining us again. Good to see you guys.
Damian Finio - Phibro Animal Health Corporation - CFO
Good to see you, Michael, and thanks for having us.
Questions and Answers:
Michael Leonidovich Ryskin - BofA Securities, Research Division - Director in Equity Research & Research AnalystOf course, always a pleasure. I think just to get the ball rolling, I would [that] sort of just as an introductory question to make sure everyone is on the same page, you reported your fiscal second quarter results a few weeks ago, strong